<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE rss PUBLIC "-//Netscape Communications//DTD RSS 0.91//EN"
            "http://my.netscape.com/publish/formats/rss-0.91.dtd">

<rss version="0.91">
 <channel>
  <title>PRWeb:  Technology  Biotechnology</title>
  <link>http://www.prweb.com</link>
  <description>Latest news releases for Technology  Biotechnology</description>
  <language>en</language>
  <image>
   <title>PRWeb Distribution Newswire</title>
   <url>http://www.prweb.com/images_v4/prw_logo.jpg</url>
   <link>www.prweb.com</link>
   <width>163</width>
   <height>51</height>
  </image>
  <managingEditor>xml@emediawire.com</managingEditor>
  <webMaster>xml@emediawire.com</webMaster>
<item>
     <title>LASIK Surgeon Pioneers and Innovators from Trusted LASIK Surgeons Directory Discuss FDA Panel Review of LASIK</title>
     <link>http://www.prweb.com/releases/FDA_Lasik/Trusted_Lasik_Surgeons/prweb939244.htm</link>
      <description> <![CDATA[  <P>Trusted LASIK Surgeons asked a few of the refractive surgery experts who are listed in its LASIK Surgeons Directory to comment on the recently concluded FDA&#039;s Ophthalmic Device Panel hearing on LASIK.  San Diego LASIK Surgeon Dr. Perry Binder of Gordon Binder Weiss Vision Institute, Dr. Daniel Durrie of Durrie Vision in Kansas City,  Dr. James J. Salz, President of Trusted LASIK Surgeons and Laser Vision Medical Associates in Los Angeles, and Atlanta LASIK Surgeon Dr. George O. Waring, III  of InView Vision,  generally agreed that the FDA panel will lead to better outcomes from LASIK eye surgery, and thereby benefit both patients and surgeons alike. Each surgeon provided some additional insights into LASIK and the FDA panel. (PRWeb May 15, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/FDA_Lasik/Trusted_Lasik_Surgeons/prweb939244.htm">http://www.prweb.com/releases/FDA_Lasik/Trusted_Lasik_Surgeons/prweb939244.htm</a></P>]]></description>
     </item>
<item>
     <title>Dotmatics Has Licensed its Browser &#38; Pinpoint Products to Arrow Therapeutics</title>
     <link>http://www.prweb.com/releases/2008/05/prweb935914.htm</link>
      <description> <![CDATA[  <P>Scientific software company Dotmatics is pleased to announce that Arrow Therapeutics (Arrow) has licensed Dotmatics&#039; browser &#38; pinpoint software to facilitate information access and project management. The solution will be used by Arrow to query, browse, analyse and share key drug discovery information across research programs and project teams. (PRWeb May 14, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb935914.htm">http://www.prweb.com/releases/2008/05/prweb935914.htm</a></P>]]></description>
     </item>
<item>
     <title>Dr. Virgil Amend is Cracking The Code of Sexual Chemistry with Pheromones </title>
     <link>http://www.prweb.com/releases/pheromone/advantage/prweb887514.htm</link>
      <description> <![CDATA[  <P>A precise concentration of pheromones can kick off a rush of chemicals in the brain within a matter of seconds, and can make people feel a strong emotional and physical response. &quot;The next thing we know, the fireworks begin,&quot; says Dr. Amend (PRWeb May 13, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/pheromone/advantage/prweb887514.htm">http://www.prweb.com/releases/pheromone/advantage/prweb887514.htm</a></P>]]></description>
     </item>
<item>
     <title>Nanopoint Names Brian Weatherly as Director of Sales</title>
     <link>http://www.prweb.com/releases/2008/05/prweb937864.htm</link>
      <description> <![CDATA[  <P>Nanopoint announces the addition of Brian Weatherly as Director of Sales to the executive team. Weatherly will pay an immediate key role in Nanopoint&#039;s June launch of the cellTRAY&#174; Imaging System Model CT-2000 and in alerting the targeted end-user markets that the cellTRAY Fluidics System Model CT-2000F will be commercially available for purchase. (PRWeb May 13, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb937864.htm">http://www.prweb.com/releases/2008/05/prweb937864.htm</a></P>]]></description>
     </item>
<item>
     <title>Bringing The Value of Complex Scientific Research into Focus</title>
     <link>http://www.prweb.com/releases/2008/05/prweb934964.htm</link>
      <description> <![CDATA[  <P>Mains Associates&#039; Science Intelligence newsletter helps readers and businesses understand the implications and impacts of today&#039;s hottest scientific subjects in a comprehensive and easy-to-understand format. (PRWeb May 13, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb934964.htm">http://www.prweb.com/releases/2008/05/prweb934964.htm</a></P>]]></description>
     </item>
<item>
     <title>Compliance with Massachusetts Healthcare Reform Simplified by New Software from Benefit Corporation of America:    Meets Challenging Demands of Massachusetts Healthcare ReformCompliance Including HIRD Form Management</title>
     <link>http://www.prweb.com/releases/massachusetts/complypro_express/prweb936314.htm</link>
      <description> <![CDATA[  <P>Benefit Corporation of America, a leading provider of technology-enabled services for the Health and Welfare employee benefit markets, today announced the launch of ComplyPRO eXpress(TM), a new web-based compliance management solution focused on Massachusetts healthcare reform. ComplyPRO eXpress(TM) offers unprecedented efficiency, ease and control, enabling companies to focus on their own business rather than on state mandated healthcare compliance activities. (PRWeb May 12, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/massachusetts/complypro_express/prweb936314.htm">http://www.prweb.com/releases/massachusetts/complypro_express/prweb936314.htm</a></P>]]></description>
     </item>
<item>
     <title>Open Source Clinical Trial Software Gets Attention at DIA Annual Meeting </title>
     <link>http://www.prweb.com/releases/2008/05/prweb932994.htm</link>
      <description> <![CDATA[  <P>Using open source clinical trial software in regulatory environments will be the topic of a panel discussion at the upcoming DIA annual meeting on June 24th in Boston (PRWeb May 12, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb932994.htm">http://www.prweb.com/releases/2008/05/prweb932994.htm</a></P>]]></description>
     </item>
<item>
     <title>Precision Stability Storage Expanding into New England</title>
     <link>http://www.prweb.com/releases/2008/05/prweb921504.htm</link>
      <description> <![CDATA[  <P>Precision Stability Storage, LLC (PSS) announced today that it is finalizing plans to open a new facility in New England. The expansion is expected to be made in a few stages over the next several months. (PRWeb May 8, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb921504.htm">http://www.prweb.com/releases/2008/05/prweb921504.htm</a></P>]]></description>
     </item>
<item>
     <title>Amphora Research Systems Launches Custodian&#039;s Console</title>
     <link>http://www.prweb.com/releases/2008/05/prweb922914.htm</link>
      <description> <![CDATA[  <P>Amphora Research Systems (<a href="http://www.amphora-research.com" onclick="linkClick( this.href );"  target="_blank">http://www.amphora-research.com</a>), a key provider of Patent Evidence Systems, is launching its new Custodian&#039;s Console to give those responsible for the integrity and performance of the Patent Evidence process more visibility and control.  With clear graphical displays highlighting  research  throughput and signature compliance plus a one-click option to verify the integrity of the document repository, the console puts control in the hands of the Custodian. (PRWeb May 7, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb922914.htm">http://www.prweb.com/releases/2008/05/prweb922914.htm</a></P>]]></description>
     </item>
<item>
     <title>Red Wine Nutritional Supplement Manufacturer Offers 30 Day Free Trial of Resmedin&#8482;, a Super Antioxidant Resveratrol Product</title>
     <link>http://www.prweb.com/releases/2008/05/prweb909424.htm</link>
      <description> <![CDATA[  <P>Resmedin&#8482; by Resmedin Nutraceuticals -- a red wine nutritional supplement that features the super antioxidant resveratrol announces a new marketing plan designed to allow everyone to try the supplement free for 30 days. (PRWeb May 6, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb909424.htm">http://www.prweb.com/releases/2008/05/prweb909424.htm</a></P>]]></description>
     </item>
<item>
     <title>New Promotion Launched: Get 1 Free Pack of Feline Leukemia and Feline Immunodeficiency Virus Treatment Aid from IMULAN</title>
     <link>http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm</link>
      <description> <![CDATA[  <P>Save on Lymphocyte T-Cell Immunomodulator (LTCI) from IMULAN BioTherapeutics, the first and only conditionally approved treatment aid in the United States for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV or Feline AIDS) infections. (PRWeb May 6, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm">http://www.prweb.com/releases/feline-leukemia/felv-fiv/prweb908854.htm</a></P>]]></description>
     </item>
<item>
     <title>Orth Brings Biochemistry/Biotech Experience in Crop Protection to Critical Path Services</title>
     <link>http://www.prweb.com/releases/wilmington/critical/prweb921124.htm</link>
      <description> <![CDATA[  <P>Critical Path Services, LLC (CPS), continues to attract top talent with the addition of Dr. Ann Orth as Business Development Manager. Orth brings 24 years of experience and education in the regulated scientific industry to this growing contract research organization and plenty of enthusiasm for the company. (PRWeb May 6, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/wilmington/critical/prweb921124.htm">http://www.prweb.com/releases/wilmington/critical/prweb921124.htm</a></P>]]></description>
     </item>
<item>
     <title>One Day the Tooth Fairy Could Save a Child&#039;s Life</title>
     <link>http://www.prweb.com/releases/2008/05/prweb916064.htm</link>
      <description> <![CDATA[  <P>Connectionsforwomen.com is showcasing BioEDEN, a remarkable bio-science company which is the first in the world to collect, assess and cryogenically store living tooth cells which then hold the potential to save a life by way of treatment for a life-threatening disease or debilitating condition that may occur in the lifetime of the donor or may be used also to treat a blood relative. (PRWeb May 6, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb916064.htm">http://www.prweb.com/releases/2008/05/prweb916064.htm</a></P>]]></description>
     </item>
<item>
     <title>Grid Dynamics and GridGain Systems Join Forces to Simplify High Performance Grid Computing for the Enterprises </title>
     <link>http://www.prweb.com/releases/high_performance/grid_computing/prweb909224.htm</link>
      <description> <![CDATA[  <P>Partnership between grid computing pioneers advances high performance grid computing with a powerful Java-based open source platform and end-to-end professional services, enabling clients to leverage grid computing quickly, cost-effectively and with less risk. (PRWeb May 5, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/high_performance/grid_computing/prweb909224.htm">http://www.prweb.com/releases/high_performance/grid_computing/prweb909224.htm</a></P>]]></description>
     </item>
<item>
     <title>Applied Biosystems &#38; Bio-Rad Gain Gene Expression Profiling Market Share:    Dynamic Gene Expression Profiling Market Revealed in PerceptaAssociates New Gene Expression Profiling Life Science DashboardTMMarket Research Report</title>
     <link>http://www.prweb.com/releases/market/expression/prweb916744.htm</link>
      <description> <![CDATA[  <P>Today Percepta Associates Inc. announced the release of Series Two of its Gene Expression Profiling Life Science DashboardTM market research report. Drawing comparisons to the findings of Series One published in February 2007, Percepta reports measurable shifts in market share within this market. (PRWeb May 5, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/market/expression/prweb916744.htm">http://www.prweb.com/releases/market/expression/prweb916744.htm</a></P>]]></description>
     </item>
<item>
     <title>2008 Life Science Industry Awards Finalists Announced by The Scientist</title>
     <link>http://www.prweb.com/releases/science/scientist/prweb917814.htm</link>
      <description> <![CDATA[  <P>Finalists have been announced for the 2008 Life Science Industry Awards, which recognize those life science suppliers that are best-in-class in both product categories and customer communications and support categories. The 45 finalists represent the five companies receiving the highest overall scores in each of 20 award categories. The finalists were selected from the more than 500 companies nominated. (PRWeb May 5, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/science/scientist/prweb917814.htm">http://www.prweb.com/releases/science/scientist/prweb917814.htm</a></P>]]></description>
     </item>
<item>
     <title>Colorado BioScience Association Announces Nine New Board Members</title>
     <link>http://www.prweb.com/releases/2008/05/prweb914034.htm</link>
      <description> <![CDATA[  <P>Nine new board members have been elected to the Colorado BioScience Association (CBSA) 40-member Board of Directors.  In related action, seven existing members were elected to reappointments on the CBSA board this year.  CBSA, with more than 400 members, is a not-for-profit corporation providing services and support for Colorado&#039;s growing biosciences industry. (PRWeb May 4, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb914034.htm">http://www.prweb.com/releases/2008/05/prweb914034.htm</a></P>]]></description>
     </item>
<item>
     <title>Baxa Announces Colorado BioScience Association Sponsorship</title>
     <link>http://www.prweb.com/releases/2008/05/prweb907994.htm</link>
      <description> <![CDATA[  <P>Baxa Corporation recognizes the work of the Colorado Bioscience Association (CBSA) on behalf of the Colorado medical device industry through a corporate sponsorship for 2008.  Through the years, Baxa has provided support for CBSA events and activities without a formal sponsorship grant.  The company&#039;s investment underlines its support of CBSA initiatives for industry growth, networking and professional education. (PRWeb May 3, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb907994.htm">http://www.prweb.com/releases/2008/05/prweb907994.htm</a></P>]]></description>
     </item>
<item>
     <title>Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases</title>
     <link>http://www.prweb.com/releases/2008/05/prweb911814.htm</link>
      <description> <![CDATA[  <P>Replikins, Ltd. has found that the replikin concentration of West Nile Virus increased annually through two  distinct cycles as the virus expanded in the U.S.: the first from 2000 to 2003, and the second from 2004 to 2007 (p less than 0.001). Increases in the annual number of human cases followed each of the virus replikin concentration increases. (PRWeb May 2, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb911814.htm">http://www.prweb.com/releases/2008/05/prweb911814.htm</a></P>]]></description>
     </item>
<item>
     <title>CoreValve Names Vito A. Canuso III as Vice President, Intellectual Property</title>
     <link>http://www.prweb.com/releases/corevalve/canuso/prweb912704.htm</link>
      <description> <![CDATA[  <P>CoreValve (<a href="http://www.corevalve.com" onclick="linkClick( this.href );"  target="_blank">www.corevalve.com</a>) announced today that it has appointed Vito A. Canuso III as Vice President, Intellectual property. In this position, Mr. Canuso&#039;s immediate focus will include managing the worldwide patent litigation with Edwards Lifesciences. He also will assume responsibilities for expanding CoreValve&#039;s global patent portfolio and for developing IP strategies that are intended to enhance CoreValve&#039;s growing leadership position in the transcatheter heart valve therapy market. (PRWeb May 2, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/corevalve/canuso/prweb912704.htm">http://www.prweb.com/releases/corevalve/canuso/prweb912704.htm</a></P>]]></description>
     </item>
<item>
     <title>Norton &#38; Associates Inc. Provides; Global Private Investment Funding, Carbon Offset Credits, Commercial Real Estate Investment for Retirement, Resort and Recreational Properties NC, SC, GA, TN &#38; VA. </title>
     <link>http://www.prweb.com/releases/2008/05/prweb905704.htm</link>
      <description> <![CDATA[  <P>Robert H. Norton, President of Norton &#38; Associates Inc., providing P &#38; L Investment Management, Commercial Real Estate Development announcement of a P &#38; L contract to provide private investment funding for a 3,100 acre, Waterfront Sportsman Retreat known as Currituck Point, Hyde County, North Carolina. This Phase I , $30M investment package brings the total asset management over $600M using Global Private Investment Funds. (PRWeb May 2, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb905704.htm">http://www.prweb.com/releases/2008/05/prweb905704.htm</a></P>]]></description>
     </item>
<item>
     <title>Baxa Launches Microsite Featuring the MedBoard Medication Tracking System</title>
     <link>http://www.prweb.com/releases/2008/05/prweb907774.htm</link>
      <description> <![CDATA[  <P>Baxa announces the launch of a microsite dedicated to its MedBoard Medication Tracking System featuring enhanced product information and interactive demonstration tools.  Customers can use the site&#039;s interactive tools to explore MedBoard features and benefits, as well as download documents covering frequently asked questions and key product attributes. (PRWeb May 2, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb907774.htm">http://www.prweb.com/releases/2008/05/prweb907774.htm</a></P>]]></description>
     </item>
<item>
     <title>King Abdullah University of Science and Technology (KAUST) Announces Inaugural Global Research Partnership (GRP) Center Grants</title>
     <link>http://www.prweb.com/releases/KAUST-global-research/42008/prweb908084.htm</link>
      <description> <![CDATA[  <P>Research proposals from four universities selected for global significance and potential economic impact in the areas of applied mathematics, molecular photovoltaics, nanomaterials and computational science. Cornell University, the University of Oxford, Stanford University, and Texas A&#38;M University will be the inaugural KAUST Global Research Partnership centers. (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/KAUST-global-research/42008/prweb908084.htm">http://www.prweb.com/releases/KAUST-global-research/42008/prweb908084.htm</a></P>]]></description>
     </item>
<item>
     <title>King Abdullah University of Science and Technology (KAUST) Selects Three Universities for Center-In-Development Grants</title>
     <link>http://www.prweb.com/releases/KAUST-Global-Research/42008/prweb908964.htm</link>
      <description> <![CDATA[  <P>Support links KAUST to King Fahd University of Petroleum and Minerals, National Taiwan University and Utrecht University to build research capacity through KAUST&#039;s Global Research Partnership (GRP). (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/KAUST-Global-Research/42008/prweb908964.htm">http://www.prweb.com/releases/KAUST-Global-Research/42008/prweb908964.htm</a></P>]]></description>
     </item>
<item>
     <title>Mayo Clinic Researchers Discover Novel Approach to Estimate Risk of Breast Cancer </title>
     <link>http://www.prweb.com/releases/Mayo_Clinic/Breast_Cancer/prweb910034.htm</link>
      <description> <![CDATA[  <P>In a paper published today, a team of medical researchers from the <a href="http://www.mayoclinic.com" onclick="linkClick( this.href );"  target="_blank" title="Mayo Clinic">Mayo Clinic</a> report on the outcome of a study that analyzes the risk for breast cancer imparted by inherited mutations in the BRCA2 gene. (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/Mayo_Clinic/Breast_Cancer/prweb910034.htm">http://www.prweb.com/releases/Mayo_Clinic/Breast_Cancer/prweb910034.htm</a></P>]]></description>
     </item>
<item>
     <title>Neuroscience &#38; Spine Institute and Department of Emergency Medicine at Carolinas Medical Center Successfully Completes Research Project with Clinipace&#039;s Web-Based Software </title>
     <link>http://www.prweb.com/releases/2008/05/prweb907404.htm</link>
      <description> <![CDATA[  <P>Research phase of large scale investigator-initiated study conducted across multiple clinical sites successfully completed 79% faster (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb907404.htm">http://www.prweb.com/releases/2008/05/prweb907404.htm</a></P>]]></description>
     </item>
<item>
     <title>NovaRx Selects ISI&#039;s eCTDXPress and ISIWriter:    --  San Diego-based biopharmaceutical company adopts flexible        package of regulatory submission products   --  Regulatory submissions for various cancer treatments easily        assembled in eCTD format</title>
     <link>http://www.prweb.com/releases/novarx/submission/prweb909524.htm</link>
      <description> <![CDATA[  <P>Image Solutions, Inc. (ISI), a leader in providing software and services to streamline the drug development and regulatory approval process, today announced that NovaRx, a privately held biopharmaceutical company based in San Diego, California, has selected its regulatory submission package. The company has purchased eCTDXPress, ISI&#039;s flagship electronic submission software, as well as ISIWriter, the industry&#039;s most robust set of global authoring templates for developing submission-ready documents. (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/novarx/submission/prweb909524.htm">http://www.prweb.com/releases/novarx/submission/prweb909524.htm</a></P>]]></description>
     </item>
<item>
     <title>Wall Street Detectives and Texas A&#38;M Offer New Equine DNA CODIS: This Year a Historical Event Occurred in the Horse World -- a CODIS Identification System for Horses </title>
     <link>http://www.prweb.com/releases/2008/05/prweb895794.htm</link>
      <description> <![CDATA[  <P>This proven low-cost tool of identification now brings justice and safety to the Horse and is based upon the same process as the FBI&#039;s own CODIS crime laboratory. (PRWeb May 1, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/05/prweb895794.htm">http://www.prweb.com/releases/2008/05/prweb895794.htm</a></P>]]></description>
     </item>
<item>
     <title>BIT Group Expands Global Field Services to North America</title>
     <link>http://www.prweb.com/releases/2008/04/prweb891994.htm</link>
      <description> <![CDATA[  <P>Global contract manufacturer of complex medical instrumentation has expanded its field services to North America.  BIT Group&#039;s USA Field Service Center operates from Source Scientific LLC (Irvine, CA), a BIT Group Company. (PRWeb Apr 30, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/04/prweb891994.htm">http://www.prweb.com/releases/2008/04/prweb891994.htm</a></P>]]></description>
     </item>
<item>
     <title>Medical Imaging Management Leader M2S Names Ciaran Cooper General Manager of Clinical Trials Services Division </title>
     <link>http://www.prweb.com/releases/medical/imaging/prweb898884.htm</link>
      <description> <![CDATA[  <P>M2S Inc., an industry leader in medical image management and analysis, announced today that it has named Ciaran Cooper its new General Manager of Clinical Trials Services. Cooper was previously Vice President of Clinical Trials Services at M2S, which he joined in March 2007. Before joining M2S, Cooper was with Beacon Bioscience (now ICON Medical Imaging) an imaging core lab servicing the pharmaceutical industry. (PRWeb Apr 30, 2008)</P>
                        <P>Read the full story at <a href="http://www.prweb.com/releases/medical/imaging/prweb898884.htm">http://www.prweb.com/releases/medical/imaging/prweb898884.htm</a></P>]]></description>
     </item>
</channel>
</rss>